Epilepsy Long-term Management
On this page
Direct answer
Choice of antiseizure medication follows seizure classification: focal seizures take carbamazepine, oxcarbazepine or levetiracetam; generalised tonic-clonic seizures and juvenile myoclonic epilepsy take valproate, with levetiracetam or lamotrigine when valproate is unsuitable. Treatment after a first unprovoked seizure is deferred unless the EEG shows epileptiform activity, imaging shows a lesion, or the seizure occurred with a neurological deficit — two unprovoked seizures more than 24 hours apart define epilepsy and start therapy. Monotherapy at the lowest effective dose, gradual titration, and lifestyle counselling frame daily care; drug withdrawal is considered after at least two seizure-free years, tapered slowly over six months or more, best in patients with normal imaging and EEG. In Asian populations, carbamazepine carries the HLA-B*1502 Stevens-Johnson risk.
What you must remember
- Syndrome-drug pairs: juvenile myoclonic epilepsy — valproate first, lifelong tendency, avoid carbamazepine which can worsen it; absence epilepsy in children — ethosuximide or valproate; focal — carbamazepine/oxcarbazepine/levetiracetam; Lennox-Gastaut — valproate, lamotrigine or Rufinamide as adjuncts.
- Start-treatment rules: two unprovoked seizures (over 24 hours apart), or one seizure with epileptogenic lesion on MRI, epileptiform EEG, or a fixed neurological deficit; provoke-only seizures (alcohol withdrawal, hypoglycaemia) treat the provoker, not with antiepileptics.
- Titration principle: monotherapy first, slow increments, therapeutic drug monitoring mainly for phenytoin (zero-order kinetics) and phenobarbitone; levetiracetam needs no routine levels.
- Toxicity fingerprints: phenytoin — gingival hyperplasia, hirsutism, cerebellar signs, megaloblastic anaemia (folate); carbamazepine — hyponatraemia, agranulocytosis, rash; valproate — weight gain, tremor, polycystic ovarian syndrome, hepatotoxicity, neural tube defects; lamotrigine — rash, slow titration with valproate co-therapy.
- Withdrawal discipline: minimum two seizure-free years, taper over at least six months, highest relapse safety in normal MRI and EEG; withdraw one drug at a time in polytherapy.
- Women of reproductive age: valproate is the highest-risk teratogen among antiseizure drugs (neural tube and neurodevelopmental effects) — switch pre-conception where possible, folate 5 mg daily, and prefer lamotrigine or levetiracetam.
- Asian pharmacogenomics: HLA-B*1502 positivity (common in Han Chinese and south Asian populations) predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis — counsel and consider alternatives.
- Non-pharmacological layers: surgery (resection for drug-resistant focal epilepsy with a resectable focus), vagus nerve stimulation, and the ketogenic diet for refractory paediatric epilepsies; seizure first aid — recovery position, never force objects into the mouth.
How to work through a new-diagnosis consultation
A 21-year-old man is referred after a generalised tonic-clonic seizure at breakfast, with bilateral arm jerks within seconds of onset. He reports early-morning myoclonic jerks since his teens and absences at school. The EEG shows generalised 4-6 Hz polyspike-and-wave discharges; MRI is normal. This is juvenile myoclonic epilepsy, and the two decisions follow: start valproate — the drug of choice for this syndrome; in a woman of reproductive age, levetiracetam or lamotrigine instead — and counsel that JME is typically lifelong: mornings need protecting (sleep debt and alcohol are his triggers), and withdrawal attempts usually relapse.
Contrast a 34-year-old with focal aware seizures progressing to tonic-clonic seizures, whose MRI shows left mesial temporal sclerosis and whose EEG shows left temporal epileptiform activity. She starts levetiracetam (carbamazepine is classical, but HLA-B*1502 caution tilts many Indian neurologists), and after two drugs fail at adequate doses she is drug-resistant by definition — the ILAE criterion — and goes for presurgical evaluation, where anterior temporal lobectomy offers a genuine chance of seizure freedom that no third tablet can.
How the FMGE frames it
The examiner tests the syndrome-drug pair more than the molecule's pharmacokinetics: JME with a carbamazepine option (a planted error — it worsens generalised epilepsies), absence epilepsy with an ethosuximide option, and status epilepticus questions belonging to their own topic. The first-seizure treatment rule (treat after two, or one with high-risk features) appears as vignettes with an EEG or MRI detail hidden mid-stem. Toxicity one-liners — phenytoin's gingival hyperplasia and megaloblastic anaemia, carbamazepine's hyponatraemia, valproate's PCOS-teratogenicity profile — recur annually. The distinctly Indian layer is HLA-B*1502 screening for carbamazepine in south Asian ancestry, alongside social counselling points (marriage, employment, driving restrictions) that Indian vignettes embed to test whether the candidate treats the person, not just the seizure.
Frequently asked questions
When should antiepileptic drug therapy begin?
After two unprovoked seizures more than 24 hours apart, or after a single seizure with an epileptiform EEG, structural lesion on MRI, or a fixed neurological deficit.
Which drug is first line for juvenile myoclonic epilepsy?
Valproate, the broad-spectrum drug of choice; levetiracetam or lamotrigine when valproate is unsuitable, as in women planning pregnancy.
What is the HLA-B*1502 association?
Carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in genetically susceptible south and east Asian patients, warranting avoidance of carbamazepine in carriers.
After how long seizure-free can drug withdrawal be considered?
At least two years, tapered over six months or longer, with the best outcomes in patients with normal neurological examination, MRI and EEG.
When is epilepsy surgery considered?
Drug-resistant epilepsy — failure of two appropriately chosen and tolerated antiseizure medications — with presurgical evaluation for a resectable focus such as mesial temporal sclerosis.